Welcome to the Brussels Edition, Bloomberg’s daily briefing on what matters most in the heart of the European Union.
Europe’s most valuable company, Novo Nordisk, now has a market capitalization of more than $570 billion — bigger than the entire Danish economy. Without the blockbuster success of Ozempic and Wegovy, the Danish economy would have stagnated. Its income tax bill at home in Denmark last year of $2.3 billion helped drive record government spending on defense, the green transition and support for Ukraine. The company’s agenda influences educational and research priorities, and politicians consider its perspective before making decisions on immigration policy or new infrastructure development. Read our deep dive on how Novo’s enormous scale comes with risks — both for the company and its home market.
Source link : https://www.bloomberg.com/news/newsletters/2024-05-02/denmark-is-hooked-on-novo-nordisk-s-success
Author :
Publish date : 2024-05-01 07:00:00
Copyright for syndicated content belongs to the linked Source.
